← Leaderboards
Maria E Arcila
Sloan-Kettering Inst Can Research
$896,260
Attributed
$1,792,519
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $404.9K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,792,519 · 1
By mechanism
U01$1,792,519 · 1
Top collaborators
- Howard I Scher5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Charles L Sawyers$34,701,646
- Brett Stewart Carver$12,016,524
- Nagavarakishore Pillarsetty$8,324,037
- Kojo Seys Elenitoba-Johnson$15,478,914
- Jessica Scott$10,593,887
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortCollectionClinical Trials DesignAndrogen ReceptorAliquotClinical TrialsAbirateroneClinical PracticeBiological FactorsBiological MarkersBiopsy SpecimenBloodBlood-Based BiomarkerCancer CellCancer PatientAtlasesAffectCell CountCell Free DnaCellular AssayChemotherapyClinicClinical ImplementationCommunities
Grant awards (5)
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa$189,163
U01 · FY2024 · CA · contact PI
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa$396,790
U01 · FY2023 · CA · contact PI
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa$396,790
U01 · FY2022 · CA · contact PI
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa$404,888
U01 · FY2021 · CA · contact PI
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa$404,888
U01 · FY2020 · CA · contact PI